[HTML][HTML] The molecular basis of neurodegeneration in multiple sclerosis
H Lassmann, J van Horssen - FEBS letters, 2011 - Elsevier
Studies aimed to elucidate the pathogenesis of the disease and to find new therapeutic
options for multiple sclerosis (MS) patients heavily rely on experimental autoimmune …
options for multiple sclerosis (MS) patients heavily rely on experimental autoimmune …
The molecular basis of neurodegeneration in multiple sclerosis
H Lassmann, J van Horssen - FEBS Letters, 2011 - ui.adsabs.harvard.edu
Studies aimed to elucidate the pathogenesis of the disease and to find new therapeutic
options for multiple sclerosis (MS) patients heavily rely on experimental autoimmune …
options for multiple sclerosis (MS) patients heavily rely on experimental autoimmune …
[PDF][PDF] The molecular basis of neurodegeneration in multiple sclerosis
H Lassmann, J van Horssen - FEBS Letters, 2011 - core.ac.uk
abstract Studies aimed to elucidate the pathogenesis of the disease and to find new
therapeutic options for multiple sclerosis (MS) patients heavily rely on experimental …
therapeutic options for multiple sclerosis (MS) patients heavily rely on experimental …
[引用][C] The molecular basis of neurodegeneration in multiple sclerosis
H Lassmann, J van Horssen - FEBS Letters, 2011 - cir.nii.ac.jp
The molecular basis of neurodegeneration in multiple sclerosis
H Lassmann, J van Horssen - FEBS Letters, 2011 - Wiley Online Library
Studies aimed to elucidate the pathogenesis of the disease and to find new therapeutic
options for multiple sclerosis (MS) patients heavily rely on experimental autoimmune …
options for multiple sclerosis (MS) patients heavily rely on experimental autoimmune …
The molecular basis of neurodegeneration in multiple sclerosis
H Lassmann, J van Horssen - FEBS Letters, 2011 - infona.pl
Studies aimed to elucidate the pathogenesis of the disease and to find new therapeutic
options for multiple sclerosis (MS) patients heavily rely on experimental autoimmune …
options for multiple sclerosis (MS) patients heavily rely on experimental autoimmune …
[PDF][PDF] The molecular basis of neurodegeneration in multiple sclerosis
H Lassmann, J van Horssen - FEBS Letters, 2011 - researchgate.net
abstract Studies aimed to elucidate the pathogenesis of the disease and to find new
therapeutic options for multiple sclerosis (MS) patients heavily rely on experimental …
therapeutic options for multiple sclerosis (MS) patients heavily rely on experimental …
The molecular basis of neurodegeneration in multiple sclerosis
H Lassmann, J van Horssen - FEBS letters, 2011 - pubmed.ncbi.nlm.nih.gov
Studies aimed to elucidate the pathogenesis of the disease and to find new therapeutic
options for multiple sclerosis (MS) patients heavily rely on experimental autoimmune …
options for multiple sclerosis (MS) patients heavily rely on experimental autoimmune …
[引用][C] The molecular basis of neurodegeneration in multiple sclerosis
H Lassmann, J van Horssen - FEBS Letters, 2011 - hero.epa.gov
The molecular basis of neurodegeneration in multiple sclerosis | Health & Environmental
Research Online (HERO) | US EPA Jump to main content US EPA United States Environmental …
Research Online (HERO) | US EPA Jump to main content US EPA United States Environmental …
[PDF][PDF] The molecular basis of neurodegeneration in multiple sclerosis
H Lassmann, J van Horssen - FEBS Letters, 2011 - cyberleninka.org
abstract Studies aimed to elucidate the pathogenesis of the disease and to find new
therapeutic options for multiple sclerosis (MS) patients heavily rely on experimental …
therapeutic options for multiple sclerosis (MS) patients heavily rely on experimental …